• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550275-28
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Atrial Fibrillation (1729)
Event Date 02/15/2020
Event Type  Injury  
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of atrial arrhythmias/fibrillation is listed in the xience sierra everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that on (b)(6) 2020 the patient presented with a non-st elevated myocardial infarction (nstemi) therefore the 2.75x28mm xience alpine was implanted.On (b)(6) 2020 the patient was re-admitted due to atrial fibrillation, and other cardiovascular symptoms.It is unknown what treatment was performed and the final patient outcome is unknown.No additional information was provided.
 
Manufacturer Narrative
Nab1- product problem removed.B5 - case details updated to reflect the complaint device was a xience sierra.
 
Event Description
It was reported that on (b)(6) 2020 the patient presented with non-st elevated myocardial infraction (nstemi) therefore the 2.75x28mm xience alpine was implanted.On (b)(6) 2020 the patient was re-admitted due to atrial fibrillation, and other cardiovascular symptoms.It is unknown what treatment was performed and the final patient outcome is unknown.Additional information was received and the correct device used in the procedure is a 2.75x28mm xience sierra stent.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10169342
MDR Text Key195608754
Report Number2024168-2020-05144
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227202
UDI-Public08717648227202
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 10/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/04/2020
Device Model Number1550275-28
Device Catalogue Number1550275-28
Device Lot Number9032841
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/28/2020
Initial Date FDA Received06/18/2020
Supplement Dates Manufacturer Received10/13/2020
Supplement Dates FDA Received10/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
Patient Weight87
-
-